Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
Top Cited Papers
- 20 September 2013
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 382 (9896), 951-962
- https://doi.org/10.1016/s0140-6736(13)60733-3
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010The Lancet, 2013
- Body Weight and Metabolic Adverse Effects of Asenapine, Iloperidone, Lurasidone and Paliperidone in the Treatment of Schizophrenia and Bipolar DisorderCNS Drugs, 2012
- Comparative Mortality Associated With Ziprasidone and Olanzapine in Real-World Use Among 18,154 Patients With Schizophrenia: The Ziprasidone Observational Study of Cardiac Outcomes (ZODIAC)American Journal of Psychiatry, 2011
- Amisulpride Overdose Is Frequently Associated With QT Prolongation and Torsades de PointesJournal of Clinical Psychopharmacology, 2010
- International Consensus Study of Antipsychotic DosingAmerican Journal of Psychiatry, 2010
- The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary StatementsSchizophrenia Bulletin, 2009
- The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and ElaborationPLoS Medicine, 2009
- Assessment of regression-based methods to adjust for publication bias through a comprehensive simulation studyBMC Medical Research Methodology, 2009
- Combination of direct and indirect evidence in mixed treatment comparisonsStatistics in Medicine, 2004
- Antipsychotic-Induced HyperprolactinaemiaDrugs, 2004